OISHI Tetsuro 大石徹郎

… Alternative Names

大石徹郎オオイシテツロウ

Less

Researcher Number	80359877
Other IDs
Affiliation (based on the past Project Information) *help	2012 – 2015: 鳥取大学, 医学部附属病院, 講師 2007: Tottori University, Faculty of Medicine, Assistant Professor 2004: 鳥取大, 医学部, 助手 2003: 鳥取大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology
Keywords	Principal Investigator mTOR阻害剤 / PI3K阻害剤 / PIK3CA / 明細胞癌 / PI3K / 明細胞腺癌 / 卵巣癌 / Galectin-3 / Clear cell carcinoma / Ovarian cancer … More Except Principal Investigator … More Chemoresponse / Gene therapy / Carcinoma / 薬剤反応性 / 遺伝子 / 癌 / FGFR2 / 卵巣明細胞腺癌 Less

Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovaryPrincipal Investigator
- Principal Investigator
  
  Oishi Tetsuro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Adenovirus type 5 EIA gene therapy for ovarian carcinoma
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
卵巣明細胞腺癌の細胞生物学的特性の解明と抗癌剤耐性克服の試みPrincipal Investigator
- Principal Investigator
  
  大石徹郎
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University

All 2015 2014 2013 2007 2006

All Journal Article Presentation

[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 20 Issue: 5 Pages: 967-973
- DOI
  10.1007/s10147-015-0811-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 25 Issue: 4 Pages: 570-576
- DOI
  10.1097/igc.0000000000000414
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24592517, KAKENHI-PROJECT-26462490
[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Journal Title
  
  Int J Clin Oncol
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014
- Author(s)
  Oishi T, Itamochi H, Kudoh A, Nonaka M, Kato M, Nishimura M, Oumi N, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Oncology Report
  
  Volume: 32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014
- Author(s)
  Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada H.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 1 Pages: 61-69
- DOI
  10.1097/igc.0000000000000014
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014
- Author(s)
  Kudoh A, Oishi T, Itamochi H, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 3 Pages: 444-453
- DOI
  10.1097/igc.0000000000000091
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013
- Author(s)
  Itamochi H., Kato M., Nishimura M., Oumi N., Oishi T., Shimada M., Sato S., Naniwa J., Sato S., Nonaka M., Kudoh A., Terakawa N., Kigawa J., and Harada T.
- Journal Title
  
  Human Cell
  
  Volume: 26 Issue: 3 Pages: 121-127
- DOI
  10.1007/s13577-013-0062-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] 卵巣明細胞腺癌におけるGalectin-3発現とCDDP感受性2007
- Author(s)
  大石徹郎
- Journal Title
  
  日本婦人科腫瘍学会誌 25
  
  Pages: 39-43
- NAID
  10026152688
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Galectin-3 and CDDP resistance in clear cell carcinoma of the ovary2007
- Author(s)
  Tetsuro, Oishi
- Journal Title
  
  Japanese Journal of Gynecological Oncology 25
  
  Pages: 39-43
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary2007
- Author(s)
  Tetsuro, Oishi
- Journal Title
  
  International Journal of Gynecological Cancer 17
  
  Pages: 1040-1046
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary.2007
- Author(s)
  Tetsuro Oishi
- Journal Title
  
  International Journal of Gynecological Cancer 17
  
  Pages: 1040-1046
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 卵巣明細胞腺癌におけるphosphatidylinositide 3-kinase (PI3K) - Akt経路およびARID1A蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、近江奈央、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第67回日本産科婦人科学会学術講演会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] 卵巣明細胞腺癌におけるPI3K-Akt 経路およびARID1A 蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第74回日本癌学会
- Place of Presentation
  愛知県名古屋市
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Saga Y, Fujiwara H, Shimada M, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Organizer
  106th Annual Meeting of the American Association for Cancer Research
- Place of Presentation
  フィラデルフィア（アメリカ合衆国）
- Year and Date
  2015-04-21
- Data Source
  KAKENHI-PROJECT-24592517
[Presentation] Galectin-3 may contribute to CDDP resistance in clear cell carcinoma of the ovary [Workshop]2006
- Author(s)
  Tetsuro, Oishi
- Organizer
  40th Annual Meeting of the Japan Society of Gynecologic Oncology
- Place of Presentation
  Gifu, Japan
- Year and Date
  2006-07-22
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Galectin-3 may contribute to CDDP resistance in clear cell carcinoma of the ovary2006
- Author(s)
  Tetsuro, Oishi
- Organizer
  97th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Washington D.C., USA
- Year and Date
  2006-04-02
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] 卵巣明細胞腺癌におけるGalectin-3発現とCDDP感受性2006
- Author(s)
  大石徹郎
- Organizer
  第58回日本産科婦人科学会
- Place of Presentation
  横浜市
- Year and Date
  2006-04-25
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Galectin-3 may contribute to CDDP resistance in clear cell carcinoma of the ovary.2006
- Author(s)
  Tetsuro Oishi
- Organizer
  97th Annual Meeting of American Association for Cancer Research
- Place of Presentation
  Washington D. C.
- Year and Date
  2006-04-02
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Galectin-3 may contribute to CDDP resistance in clear cell carcinoma of the ovary2006
- Author(s)
  Tetsuro, Oishi
- Organizer
  58th Annual Congress of the Japan Society of Obstetrics and Gynecology
- Place of Presentation
  Yokohama, Japan
- Year and Date
  2006-04-25
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] [ワークショップ]卵巣明細胞腺癌におけるGalectin-3発現とCDDP感受性2006
- Author(s)
  大石徹郎
- Organizer
  第40回日本婦人科腫瘍学会
- Place of Presentation
  岐阜市
- Year and Date
  2006-07-22
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737

1. SATO Syinya (10423261)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
2. ITAMOCHI Hiroaki (20314601)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
3. SHIMADA Muneaki (40362892)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
4. KIGAWA Junzo (00177784)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
5. SATO Seiya (30621007)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
6. HARADA Tasuku (40218649)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
7. CHIKUMI Jun (70467702)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. TARAKAWA Naoki (90163906)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 金森康展 (70283984)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 高橋正国 (30379622)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. NANIWA Jun

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results

OISHI Tetsuro 大石 徹郎

大石 徹郎 オオイシ テツロウ

Research Projects

Research Products

Co-Researchers

Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovaryPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Adenovirus type 5 EIA gene therapy for ovarian carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

卵巣明細胞腺癌の細胞生物学的特性の解明と抗癌剤耐性克服の試みPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015

Author(s)

Journal Title

Data Source

[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014

Author(s)

Journal Title

Data Source

[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 卵巣明細胞腺癌におけるGalectin-3発現とCDDP感受性2007

Author(s)

Journal Title

NAID

Description

Data Source

[Journal Article] Galectin-3 and CDDP resistance in clear cell carcinoma of the ovary2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary.2007

Author(s)

OISHI Tetsuro 大石徹郎

大石徹郎オオイシテツロウ

[Presentation] 卵巣明細胞腺癌におけるPI3K-Akt 経路およびARID1A 蛋白発現と臨床的意義の検討2015